Clinical trial finds no benefit from aspirin in preventing colorectal cancer recurrence
A new international clinical trial led by the National Cancer Center Singapore is reporting that three years of aspirin ...
MedPage Today4d
Aspirin Fails to Boost Survival in Colorectal Cancer Trial
Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly ...
FiercePharma4d
JPM25: Bayer gears up for 'must-win battles' as Xarelto's decline is in full swing, pharma chief says
These launches are what Oelrich called “must-win battles” at Bayer as the Xarelto loss of exclusivity reaches “full swing” in ...
Jury orders Bayer to pay $100 million over PCBs in Washington school
A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals ...
Health and Me on MSN5d
Daily Low Dose Of Aspirin Is Not As Good As You Think
People without the risk of heart problems who consumed daily low-dose aspirin, it increased the chance of bleeding in the ...
Bayer Says It Was Told by Jury to Pay $100 Million Over Toxic Chemicals
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the ...
Bayer Hit With $100 Million Verdict Over School’s Toxic PCBs (2)
Bayer AG was told by a jury to pay $100 million to four people at a Seattle-area school who said their exposure at the facility to toxic chemicals made by the company’s Monsanto unit caused brain ...
Bayer sees new drugs boosting return to growth in 2027, WSJ reports
Growth is on the horizon for German drug conglomerate Bayer (BAYRY), despite “falling sales of its blockbuster blood thinner Xarelto,”amid ...